QUIT:NASDAQ, Achieve Life Sciences Inc.
QUIT stock overview
Achieve Life Sciences Inc. (QUIT:NASDAQ) closed at $5.87 on November 19, 2026,
down 0.84% on the day.
The stock trades 32.1% below its 52-week high of $8.64
and 124.0% above its 52-week low of $2.62.
Over the past year, it gained 23.1%.
Achieve Life Sciences Inc. is part of the Health Care sector.
Key figures
- Price
- $5.87
- Day change
- -0.84%
- Volume
- 945,858
- Average volume
- 1,376,439
- Market cap
- 605M+
- 52-week range
- $2.62 – $8.64
- 50-day average
- $7.02
- 200-day average
- $5.74
Price action over the past year
In 129 trading sessions since May 19, 2026, QUIT closed higher on 64 days (50%).
Its best day was August 19, 2026 (+13.43%) and its worst was June 18, 2026 (-9.51%).
The stock moved 10% or more in a single session 2 times.
Recent signals
QUIT news
-
Nov 18, 2026:
QUIT: Looking Ahead to Resubmission
-
Nov 9, 2026:
Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT
-
Nov 2, 2026:
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
-
Oct 21, 2026:
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
-
Oct 15, 2026:
Lisata adds biopharma finance veteran Jeffrey Farrow to board
-
Oct 7, 2026:
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
-
Oct 1, 2026:
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
-
Sep 28, 2026:
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
About Achieve Life Sciences Inc.
That medicine is cytisinicline, an investigational compound.
Similar stocks
Find more stocks like QUIT with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.